Clinical Trial Update: Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Adults Receiving First Cytotoxic Chemotherapy for Metastatic or Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC) and Who Are Current or Former Smokers [Phase 3]

View source ↗

Summary

Phase 3 trial comparing veliparib plus carboplatin and paclitaxel versus investigator's choice chemotherapy in first-line metastatic/advanced non-squamous non-s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Veliparib (veliparib)

Snippet

Sponsor: AbbVie | Conditions: Non-squamous Non-small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2021-02-26